New tools to study the role of B cells in cytomegalovirus infections

Medical Microbiology and Immunology

Volumn 197, Issue 2, 2008, Pages 145-149

  Waisman, Ari ^a   Croxford, Andrew L ^a   Demircik, Filiz ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CRE RECOMBINASE; DIPHTHERIA TOXIN;

ANTIBODY PRODUCTION; B LYMPHOCYTE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; IMMUNE RESPONSE; LYMPHOCYTE DEPLETION; LYMPHOCYTE FUNCTION; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS LATENCY; VIRUS REACTIVATION;

ANIMALS; ANTIBODIES, VIRAL; B-LYMPHOCYTES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; LYMPHOCYTE DEPLETION; MICE; MODELS, ANIMAL;

EID: 42249097244     PISSN: 03008584     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00430-008-0088-z     Document Type: Review

References (27)

1. Reddehase MJ (2002) Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance. Nat Rev Immunol 2:831-844
2. Hsieh SM, Pan SC, Hung CC, Tsai HC, Chen MY, Chang SC (2001) Association between cytomegalovirus-specific reactivity of T cell subsets and development of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome [see comment]. J Infect Dis 184:1386-1391
3. Lilleri D, Piccinini G, Baldanti F, Seminari E, Galloni D, Gerna G (2003) Multiple relapses of human cytomegalovirus retinitis during HAART in an AIDS patient with reconstitution of CD4+ T cell count in the absence of HCMV-specific CD4+ T cell response. J Clin Virol 26:95-100
4. Rubin RH (1990) Impact of cytomegalovirus infection on organ transplant recipients. Rev Infect Dis 12 Suppl 12(Suppl 7):S754-S766
5. Crawford SW, Longton G, Storb R (1993) Acute graft-versus-host disease and the risks for idiopathic pneumonia after marrow transplantation for severe aplastic anemia. Bone Marrow Transplant 12:225-231
6. Mach M (2006) Antibody-mediated neutralization of infectivity. In: Reddehase MJ (ed) Cytomegaloviruses: molecular biology and immunology. Caister Academic Press, Norfolk (UK), pp 265-283
7. Shanley JD, Jordan MC, Stevens JG (1981) Modification by adoptive humoral immunity of murine cytomegalovirus infection. J Infect Dis 143:231-237
8. Reddehase MJ, Balthesen M, Rapp M, Jonjic S, Pavic I, Koszinowski UH (1994) The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease. J Exp Med 179:185-193
9. Farrell HE, Shellam GR (1991) Protection against murine cytomegalovirus infection by passive transfer of neutralizing and non-neutralizing monoclonal antibodies. J Gen Virol 72(Pt 1):149-156
10. Jonjic S, Pavic I, Polic B, Crnkovic I, Lucin P, Koszinowski UH (1994) Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. J Exp Med 179:1713-1717
11. Polic B, Hengel H, Krmpotic A, Trgovcich J, Pavic I, Luccaronin P, Jonjic S, Koszinowski UH (1998) Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection. J Exp Med 188:1047-1054
12. Klenovsek K, Weisel F, Schneider A, Appelt U, Jonjic S, Messerle M, Bradel-Tretheway B, Winkler TH, Mach M (2007) Protection from CMV infection in immunodeficient hosts by adoptive transfer of memory B cells. Blood 110:3472-3479
13. Cerny A, Sutter S, Bazin H, Hengartner H, Zinkernagel RM (1988) Clearance of lymphocytic choriomeningitis virus in antibody- and B-cell-deprived mice. J Virol 62:1803-1807
14. Fillatreau S, Radbruch A (2006) IRF4-a factor for class switching and antibody secretion. Nat Immunol 7:704-706
15. Ahuja A, Shupe J, Dunn R, Kashgarian M, Kehry MR, Shlomchik MJ (2007) Depletion of B cells in murine lupus: efficacy and resistance. J Immunol 179:3351-3361
16. Kessel A, Rosner I, Toubi E (2008) Rituximab: beyond simple B cell depletion. Clin Rev Allergy Immunol 34:74-79
17. Hunt KE, Reichard KK (2008) Diffuse large B-cell lymphoma. Arch Pathol Lab Med 132:118-124
18. Kitamura D, Roes J, Kuhn R, Rajewsky K (1991) A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 350:423-426
19. Mozdzanowska K, Furchner M, Maiese K, Gerhard W (1997) CD4+ T cells are ineffective in clearing a pulmonary infection with influenza type A virus in the absence of B cells. Virology 239:217-225
20. Buendia AJ, Martinez CM, Ortega N, Del Rio L, Caro MR, Gallego MC, Sanchez J, Navarro JA, Cuello F, Salinas J (2004) Natural killer (NK) cells play a critical role in the early innate immune response to Chlamydophila abortus infection in mice. J Comp Pathol 130:48-57
21. Hasan M, Polic B, Bralic M, Jonjic S, Rajewsky K (2002) Incomplete block of B cell development and immunoglobulin production in mice carrying the muMT mutation on the BALB/c background. Eur J Immunol 32:3463-3471
22. Macpherson AJ, Lamarre A, McCoy K, Harriman GR, Odermatt B, Dougan G, Hengartner H, Zinkernagel RM (2001) IgA production without mu or delta chain expression in developing B cells. Nat Immunol 2:625-631
23. Gu H, Zou YR, Rajewsky K (1993) Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting. Cell 73:1155-1164
24. Bradley LM, Harbertson J, Biederman E, Zhang Y, Bradley SM, Linton PJ (2002) Availability of antigen-presenting cells can determine the extent of CD4 effector expansion and priming for secretion of Th2 cytokines in vivo. Eur J Immunol 32:2338-2346
25. Jung S, Unutmaz D, Wong P, Sano G, De los Santos K, Sparwasser T, Wu S, Vuthoori S, Ko K, Zavala F et al (2002) In vivo depletion of CD11c(+) dendritic cells abrogates priming of CD8(+) T cells by exogenous cell-associated antigens. Immunity 17:211-220
26. Buch T, Heppner FL, Tertilt C, Heinen TJ, Kremer M, Wunderlich FT, Jung S, Waisman A (2005) A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration. Nat Methods 2:419-426
27. Waisman A, Kraus M, Seagal J, Ghosh S, Melamed D, Song J, Sasaki Y, Classen S, Lutz C, Brombacher F et al (2007) IgG1 B cell receptor signaling is inhibited by CD22 and promotes the development of B cells whose survival is less dependent on Ig{alpha}/{beta}. J Exp Med 204:747-758